alexa Treating Cancer with Snake Venom and Serum: Case Series

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Treating Cancer with Snake Venom and Serum: Case Series

Introduction: A new anti-cancer immunological approach devised and experimented for years by Dr. Fernando Ferretti, is presented. Cobra Venom Factor is incubated with filtered Naja Naja Kaouthia serum and the mix obtained is injected subcutaneously. Due to the close functional similarity between Cobra Venom Factor and human Complement C3b, as well as the likely similarity between their inhibitors, the induced antibodies are hypothesized to cross react with Complement inhibitors and help restore the immune anti-cancer mechanisms. 1.2. Methods and Results of mix component analysis: The electrophoretic analysis of Cobra Venom Factor, Naja serum and the therapeutic mix was performed and it showed that complex interactions occur between Cobra Venom Factor and serum, leading to the formation of new molecules in the mix. 1.3. Case report: We describe 8 cases of cancer treated with the present approach. Following immunogen injections, the patients generally experienced a transient increase in pain in the regions of primary and secondary cancer lesions, then the pain reduced and they felt better that before the injection. Overall, the effects observed ranged from complete healing to an increase of life duration beyond medical expectancy, together with a state of general well-being, decrease or disappearance of pain, new energy, a new positive sense of life. 1.4. Discussion: This therapy is aimed at balancing the various molecular components of the immune system, so as to restore its natural antitumor activity. A specific link is suggested between mix immunogens and the malignancy process

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords